Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia

Abstract

Newborn DB or CB measurements may have a high sensitivity and specificity for BA. Specificity can be further improved by using 99% reference intervals and/or repeat testing. Our findings can serve as the foundation for larger prospective studies, to determine whether newborn DB or CB measurements can be an effective screening strategy for BA.